| 120 | 0 | 134 |
| 下载次数 | 被引频次 | 阅读次数 |
报道1例莫西沙星注射液致肾移植受者焦虑抑郁的病例。患者因肾移植术后发生急性排斥反应伴发热入院，予以莫西沙星注射液抗感染治疗。治疗约7 h后，患者自诉出现无法控制的焦虑，不停地自责，并且控制不住地流泪。对患者进行焦虑及抑郁评分，发现患者处于焦虑抑郁状态，临床药师考虑为莫西沙星注射液引起的药物不良反应，予立即停药，1 d后患者症状完全缓解。经治疗，患者病情好转出院。
Abstract：[1]梁兴发,黄怡新,尚翔,等.莫西沙星与非甾体抗炎药潜在药物相互作用致不良反应1例[J].中南药学, 2024, 22(7):1963.
[2] KENNA H A, POON A W, PAULA DE LOS ANGELES C, et al.Psychiatric complications of treatment with corticosteroids:review with case report[J]. Psychiatry Clin Neurosci, 2011, 65(6):549.
[3] FDA Drug Safety Communication:FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects[J/OL].(2016-07-26)[2024-06-20].https://www.fda.gov/media/119537/download.
[4]杨爱娟,高华,陈洋.莫西沙星片致腺垂体功能减退症合并肺部感染患者精神异常1例[J].中国临床药学杂志, 2023, 32(1):60.
[5]吴连彬.盐酸莫西沙星不良反应1037例监测报告分析[J].山西医药杂志, 2024, 53(2):113.
[6]陈春燕,单慧亭,赵海霞,等.莫西沙星110例不良反应及其神经/精神毒性的危险因素分析[J].中国药事, 2021, 35(4):456.
[7]王宝华,于丹,朱旭,等.静脉滴注莫西沙星致幻觉及精神异常的病例分析[J].中国临床药理学杂志, 2021, 37(12):1594.
[8] NO AUTHOR. MHRA issues two updates on fluoroquinolone safety[J]. Drug Ther Bull, 2024, 62(2):19.
[9] XIE W L, GE M L, CHEN D, et al. Psychiatric disorders associated with fluoroquinolones:a pharmacovigilance analysis of the FDA adverse event reporting system database[J]. Front Pharmacol,2024, 15:1435923.
[10] SCAVONE C, MASCOLO A, RUGGIERO R, et al. Quinolonesinduced musculoskeletal, neurological, and psychiatric ADRs:a pharmacovigilance study based on data from the Italian spontaneous reporting system[J]. Front Pharmacol, 2020, 11:428.
[11] ZAREIFOPOULOSN, PANAYIOTAKOPOULOSG.Neuropsychiatric effects of antimicrobial agents[J]. Clin Drug Investig, 2017, 37(5):423.
[12] WIERZBI?SKI P, HUBSKA J, HENZLER M, et al. Depressive and other adverse CNS effects of fluoroquinolones[J].Pharmaceuticals(Basel), 2023, 16(8):1105.
基本信息:
DOI：10.19577/j.1007-4406.2025.09.011
中图分类号:R978.1
引用信息:
[1]冯丽娟,汪燕燕,苏涌,等.莫西沙星注射液致肾移植受者焦虑抑郁状态1例[J].中国临床药学杂志,2025,34(09):702-704.DOI:10.19577/j.1007-4406.2025.09.011.
基金信息:
安徽医科大学校科研基金（编号2021xkj272）
2025-09-25
2025-09-25